Credits: iStock
A team of researchers developed a novel blood test that could detect and monitor lung cancer in real time. They used the technique Fourier Transform Infrared (FT-IR) micro spectroscopy to detect a single lung cancer cell in a patient's blood. This technique combines advanced infrared scanning technology with computer analysis and focuses on the unique chemical fingerprint of cancer cells. The research has been lead by the team from University Hospitals of North Midlands NHS Trust or UHNM, Keele University, and Loughborough University.
Study's lead author Professor Josep Sulé-Suso, Associate Specialist in Oncology at UHNM, says, "This approach has the potential to help patients receive earlier diagnoses, personalized treatments, and fewer invasive procedures, and it could eventually be applied to many types of cancer beyond lung cancer."
Circulating tumor cells or CTCs are a type of cancer cell that can break away from a tumor and travel in bloodstream. They can also provide information on how the disease progresses and how well does a treatment work. CTCs are also the cells that leads to spread of cancer or what is known as metastases.
How is it novel and differ to the current methods in use? Current methods detect CTCs, but use a very complicated, expensive and time-consuming procedure. The current methods could also sometimes miss cancer cells altogether, as the cells often change their characteristics while circulating in the blood.
The researchers identify circulating tumor cells, or CTCs, in blood samples by directing a powerful infrared beam at them, similar in principle to the light used in a TV remote but much stronger.
Because different chemicals absorb infrared light in unique ways, CTCs produce a distinctive absorption signature, often described as a chemical fingerprint. Advanced computer analysis of this data can quickly determine whether tumor cells are present in the bloodstream.
Published in the journal Applied Spectroscopy, the method is both simpler and more cost-effective than current techniques. It uses standard glass slides already common in pathology laboratories, which could make it easier to incorporate into routine clinical use.
The team plans to test the approach in larger patient populations, with the goal of developing a fast, automated blood test that can be seamlessly added to cancer care pathways.
As per the World Cancer Research Fund, there were 2,480,675 new cases of lung cancer in 2022. The numbers have projected to rise significantly by 2050. Key drivers of lung cancer include tobacco usage, air pollution, and occupational exposure. There has also been a rise in lung cancer rates in women and seen disparities across regions.
What happens in lung cancer? The National Health Institute (NIH) notes that lung cancer refers to tumors originating in the lung parenchyma or within the bronchi. This is the third most common cancer in the US. Your cells divide and make more copies of themselves as a part of their normal function, however, they get mutations that cause them to keep making more of themselves when they should not. This is how damaged cells divide at an uncontrollable rate and create masses or tumor that keep your organs from working properly.
Credit: Hub News
Meghalaya's Health Minister Wailadmiki Shylla has raised alarm over the rising HIV cases in the state, noting that 10,293 infected residents were receiving antiretroviral treatment.
Along with this, Shylla noted that nearly 750 people have died due to the condition in the past decade with East Khasi Hills district reporting 435 of those cases. Coming in second is West Jaintia Hills with 123 cases, East Jaintia Hills with 90 cases, Ri Bhoi with 51 cases and Eastern West Khasi Hills reporting 16.
Nine deaths in West Garo Hills, eight in West Khasi Hills, seven in South West Khasi Hills, three in South Garo Hills, two in South West Garo Hills, and one in North Garo Hills have also been recorded.
During a question hour in an assembly session on February 25, the official said: "It is very unfortunate, but Meghalaya is having the highest cases in India".
He also highlighted the confidentiality clauses in the HIV and AIDS Prevention and Control Act, 2017 as well as existing social stigma as major challenges in addressing the rampant spread of the issue. “Early detection and intervention get complicated because testing requires consent and treatment cannot be forced,” he said.
“The State government has sanctioned a ₹25-crore intervention program for the next five years to address the alarming rise in HIV/AIDS cases,” Shylla declared as well as assured that the Department has been intensifying awareness campaigns to improve testing and treatment.
The global challenge of HIV/AIDS remains one of the most pressing public health issues today. According to the latest data from UNAIDS, around 38.4 million people worldwide are living with HIV/AIDS.
As of 2024–2025, India has approximately 2.5 million to 2.56 million people living with HIV (PLHIV), marking the third-largest HIV epidemic globally, underlining the need for not only medical intervention but also comprehensive awareness, education, and social change.
HIV is the virus responsible for attacking the body’s immune system, specifically targeting CD4 cells, which are crucial for the body’s defense against infections. As HIV progresses, it destroys these cells, weakening the immune system over time. If left untreated, this continuous damage can lead to AIDS.
HIV is highly contagious and can be transmitted through the exchange of bodily fluids such as blood, semen, vaginal fluids, and breast milk. It is primarily spread through unprotected sexual contact, sharing needles, from mother to child during childbirth or breastfeeding.
Without treatment, HIV progresses through three stages:
- Acute HIV Infection: This stage occurs shortly after transmission and may include symptoms like fever, fatigue, and swollen lymph nodes.
- Chronic HIV Infection: Often asymptomatic or mildly symptomatic, the virus continues to damage the immune system but at a slower rate.
- AIDS: This is the final stage, marked by severe immune damage and the presence of infections that take advantage of the compromised immune defenses.
The disease is diagnosed through blood tests or oral swabs that detect the presence of the virus or antibodies produced by the immune system in response to the virus. Early detection of HIV is crucial, as it allows for timely intervention and treatment, which can prevent the virus from progressing to AIDS.
For HIV, the primary treatment goal is to suppress the virus to undetectable levels, thus maintaining a strong immune system and preventing further transmission of the virus. People living with HIV can often live long, healthy lives if they adhere to antiretroviral therapy (ART).
Mizoram Health Minister Lalrinpuii has expressed serious concern about rising HIV cases, as data shows that cases in the state are 13 times higher than the national average.
Calling it a "collective disgrace", Lalrinpuii said: “About 70 per cent of HIV transmissions in Mizoram occur through sexual contact. While the national prevalence rate stands at a mere 0.2 per cent, Mizoram’s rate has climbed to 2.74 per cent. This is a matter of shame for Mizo society.”
Speaking at an event organised for International Condom Day in Aizawl on February 13, she noted that a majority of that sexual contact remains the primary route of HIV infections in the state, accounting for 70 per cent of all cases.
The minister noted that the spread is largely driven by infidelity and a lack of preventive measures, which she argued contradicted the moral and religious values of the Mizo society.
She urged the people of the state to remain faithful to their partners. “To protect the future of Mizoram, our youth must remain vigilant,” Lalrinpuii added.
Credit: Instagram
Kenyan-Mexican actress Lupita Nyong’o has revealed that her fibroids have returned after undergoing surgery in 2014 -- now doubling up to 50, raising awareness about the often-overlooked health condition in women.
Speaking at the Today show, the Oscar-winning star Nyong’o said that she was first diagnosed with fibroids, a noncancerous tumor -- about 30 in number -- in 2014.
The growths made of muscle and tissue were removed with myomectomy, the fibroid-removal surgery.
However, the fibroids came back after over a decade, with the largest being the size of an orange, Nyong’o said.
She noted that the doubled-up fibroids are causing her more pain, while her treatment options remain largely the same.
“The first time I got the fibroids taken out, they took out 23,” she said on the show. “And this time, I’ve been informed two years ago that I have over 50.”
“And I’m being faced with the same options,” she added. “Surgery or live with the pain.”
Even as she is contemplating her treatment options, the A Quiet Place: Day One star opened up about feeling left alone and scared for her reproductive health during the initial phase.
She is now speaking out and connecting with other women suffering like her. Nyong’o is also advocating and raising money for scientists to research less invasive and non-invasive treatment methods for fibroids.
I was told that fibroids were something women live with. In refuse to accept that. Millions of women are suffering in silence, and we deserve better answers, better care and better options," Nyong’o wrote in a post on Instagram.
Uterine fibroids are noncancerous growths that form inside or on the uterus. They are very common, affecting an estimated 40 to 80 percent of people with a uterus between the ages of 30 and 50.
In some cases, fibroids do not cause any noticeable symptoms, which means many people may not realize they have them. However, when symptoms are present, they often include:
Obesity and a higher body mass index (BMI) are the most common risk factors that can increase the chances of developing fibroids. Others include family history, not having children, early onset of menstruation (getting your period at a young age), and late age of menopause.
There are several tests that can be done to confirm fibroids and determine their size and location.
These tests can include ultrasonography, magnetic resonance imaging (MRI), computed tomography (CT) scan, hysteroscopy, and laparoscopy.
Myomectomy is a commonly used surgical procedure to remove fibroids. There are several types of myomectomy, and they are used depending on the location of the fibroids, their size, and number.
The types of myomectomy procedures include hysteroscopy, laparoscopy, laparotomy, hysterectomy, uterine fibroid embolization, and radiofrequency ablation (RFA).
Even after a successful myomectomy, new fibroids can still develop. The recurrence risk is more common among young adults (under age 40) with many fibroids. The risk is less among people near menopause or with few fibroids.
Visit your doctor if you have:
Credit: PA Media
For the first time, a baby boy has been born to a mother with a womb transplanted from a deceased donor at Queen Charlotte’s and Chelsea hospital in London.
Weighing merely 3.09kg (6lb 13oz), Hugo Powell was born to Grace Bell and Steve Powell from Kent, right before Christmas 2025. "It's simply a miracle. I never, ever thought that this would be possible," Bell said. "I'm the happiest I've ever been in my life. When I was 16, I was told that this would never be possible," she said of her son's birth.
The father added: "When he came over the curtain, it was just sort of overwhelming emotions. I felt like I wanted to cry, but couldn't. From where we started - first meeting - to where we are today, with Hugo, is nothing short of a miracle after everything we've been through. It just felt quite unreal at the time, because this has been a long journey for us both."
Also Read: Unique Symptoms Of Sepsis: What To Know About TIME
The couple also paid tribute to the "kindness and selflessness" of their transplant donor and her family for their "incredible gift", while also thanking medical teams in Oxford and London who supported their journey.
"There are no words to say thank you enough to my donor and her family. Their kindness and selflessness to a complete stranger is the reason I have been able to fulfil my lifelong dream of being a mum.
"I hope they know that my child will always know of their incredible gift, and the miracle that brought him into this world," Bell said.
Bell, an IT programme manager, was born with Mayer-Rokitansky-Kuster-Hauser (MRKH), a disorder that causes the vagina and uterus to be underdeveloped or absent. MRKH syndrome is also called:
Also Read: Indore Food Contamination: 6 People Hospitalized In Bhagirathpura
While women with MRKH syndrome have normal external genitalia, functioning ovaries, breast and pubic hair development, they are unable to carry a pregnancy and rely on either surrogacy or a womb transplant, as in the case of Bell.
There are two versions of the disorder:
However, these genetic changes have been found in only a small number of affected people and subsequent studies have not identified a clear association between MRKH syndrome and any specific environmental factors. It remains unclears whether they actually cause MRKH syndrome.
Treatment for MRKH depends on the patient's goals and symptoms and some options include:
"I still can't believe that I'm here today and I've gone through this. It's just amazing."
At the age of 16, the new mother was told she wouldn't be able to carry her own child. However, in 2024 she received a phone call saying a womb had been donated and a transplant was possible, a moment she recalls left her "in complete shock" and "really excited".
Bell's womb transplant operation lasted 10 hours and took place at The Churchill Hospital in Oxford in June 2024 After her transplant surgery, she began fertility treatments several months after the transplant in 2024 and her son was born a year later.
According to The Guardian, Bell's transplanted womb will be removed when the couple have finished having children, to save her from a lifetime of taking immunosuppressant drugs.
© 2024 Bennett, Coleman & Company Limited